Nanoparticles Of Cerium Oxide Targeted To An Amyloid Beta Antigen Of Alzheimers Disease And ...
The innovation consists in the ability of conjugated nanoparticles to recognize specific proteins present in the pathological tissue, and to arrive only in neurodegenerative sites in a selective manner.
Formulation of drugs for therapy of neurodegenerative diseases.
The proposed formulation is applied to Alzheimers disease.
Varying the bounding antibody, the proposal functionalization procedure, is suitable to be used also for other neurodegenerative diseases, characterized by oxidative stress, such as:
Parkinsons disease Huntingtons disease Amyotrophic lateral sclerosis (ALS) progressive supranuclear palsy frontotemporal dementia Lewy bodydementias CJD GSS.
US20150118316
US
Sale, License agreement, Other (partnership)
Issued patent
意大利
